Cargando…

Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease

OBJECT: We sought to determine the safety and efficacy in secondary stroke prevention of carotid endarterectomy (CEA) in patients with symptomatic non-stenotic carotid artery disease (SyNC). METHODS: This was a single-centre retrospective case series. All patients who underwent CEA for unilateral an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nardi, Valentina, Benson, John C, Larson, Anthony S, Brinjikji, Waleed, Saba, Luca, Meyer, Fredric B, Lanzino, Giuseppe, Lerman, Amir, Savastano, Luis E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240461/
https://www.ncbi.nlm.nih.gov/pubmed/35241631
http://dx.doi.org/10.1136/svn-2021-000939
_version_ 1784737560560402432
author Nardi, Valentina
Benson, John C
Larson, Anthony S
Brinjikji, Waleed
Saba, Luca
Meyer, Fredric B
Lanzino, Giuseppe
Lerman, Amir
Savastano, Luis E
author_facet Nardi, Valentina
Benson, John C
Larson, Anthony S
Brinjikji, Waleed
Saba, Luca
Meyer, Fredric B
Lanzino, Giuseppe
Lerman, Amir
Savastano, Luis E
author_sort Nardi, Valentina
collection PubMed
description OBJECT: We sought to determine the safety and efficacy in secondary stroke prevention of carotid endarterectomy (CEA) in patients with symptomatic non-stenotic carotid artery disease (SyNC). METHODS: This was a single-centre retrospective case series. All patients who underwent CEA for unilateral anterior circulation cerebrovascular events with ipsilateral <50% carotid stenosis from 2002 to 2020 were included. Imaging hallmarks including the degree of luminal stenosis and the presence of various vulnerable plaque characteristics (eg, intraplaque haemorrhage (IPH) on MR angiography, ulceration or low-density plaque on CT angiography) were assessed. The presence of vulnerable plaque characteristics was compared between arteries ipsilateral to the ischaemic event and contralateral arteries. The prevalence of perioperative/intraoperative complications, as well as recurrent ischaemic events at follow-up was determined. RESULTS: Thirty-two patients were included in the analysis, of which 25.0% were female. Carotid arteries ipsilateral to an ischaemic event had a significantly higher prevalence of IPH when compared with contralateral arteries (80.0% vs 0.0%; p<0.001). There were no intraoperative complications. One patient (3.1%) developed symptoms of transient ipsilateral ischaemia 1 day following CEA which resolved without treatment. In a median follow-up of 18.0 months (IQR 5.0–36.0), only one patient (3.1%) experienced a transient neurologic deficit with complete resolution (annualised rate of recurrent stroke after CEA of 1.5% for a total follow-up of 788 patient-months following CEA). All other patients (31/32, 96.9%) were free of recurrent ischaemic events. CONCLUSION: CEA appears to be safe and well-tolerated in patients with SyNC. Additional studies with larger cohorts and longer follow-up intervals are needed in order to determine the role of CEA in this patient population.
format Online
Article
Text
id pubmed-9240461
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-92404612022-07-20 Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease Nardi, Valentina Benson, John C Larson, Anthony S Brinjikji, Waleed Saba, Luca Meyer, Fredric B Lanzino, Giuseppe Lerman, Amir Savastano, Luis E Stroke Vasc Neurol Original Research OBJECT: We sought to determine the safety and efficacy in secondary stroke prevention of carotid endarterectomy (CEA) in patients with symptomatic non-stenotic carotid artery disease (SyNC). METHODS: This was a single-centre retrospective case series. All patients who underwent CEA for unilateral anterior circulation cerebrovascular events with ipsilateral <50% carotid stenosis from 2002 to 2020 were included. Imaging hallmarks including the degree of luminal stenosis and the presence of various vulnerable plaque characteristics (eg, intraplaque haemorrhage (IPH) on MR angiography, ulceration or low-density plaque on CT angiography) were assessed. The presence of vulnerable plaque characteristics was compared between arteries ipsilateral to the ischaemic event and contralateral arteries. The prevalence of perioperative/intraoperative complications, as well as recurrent ischaemic events at follow-up was determined. RESULTS: Thirty-two patients were included in the analysis, of which 25.0% were female. Carotid arteries ipsilateral to an ischaemic event had a significantly higher prevalence of IPH when compared with contralateral arteries (80.0% vs 0.0%; p<0.001). There were no intraoperative complications. One patient (3.1%) developed symptoms of transient ipsilateral ischaemia 1 day following CEA which resolved without treatment. In a median follow-up of 18.0 months (IQR 5.0–36.0), only one patient (3.1%) experienced a transient neurologic deficit with complete resolution (annualised rate of recurrent stroke after CEA of 1.5% for a total follow-up of 788 patient-months following CEA). All other patients (31/32, 96.9%) were free of recurrent ischaemic events. CONCLUSION: CEA appears to be safe and well-tolerated in patients with SyNC. Additional studies with larger cohorts and longer follow-up intervals are needed in order to determine the role of CEA in this patient population. BMJ Publishing Group 2022-03-03 /pmc/articles/PMC9240461/ /pubmed/35241631 http://dx.doi.org/10.1136/svn-2021-000939 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Nardi, Valentina
Benson, John C
Larson, Anthony S
Brinjikji, Waleed
Saba, Luca
Meyer, Fredric B
Lanzino, Giuseppe
Lerman, Amir
Savastano, Luis E
Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease
title Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease
title_full Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease
title_fullStr Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease
title_full_unstemmed Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease
title_short Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease
title_sort carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240461/
https://www.ncbi.nlm.nih.gov/pubmed/35241631
http://dx.doi.org/10.1136/svn-2021-000939
work_keys_str_mv AT nardivalentina carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease
AT bensonjohnc carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease
AT larsonanthonys carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease
AT brinjikjiwaleed carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease
AT sabaluca carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease
AT meyerfredricb carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease
AT lanzinogiuseppe carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease
AT lermanamir carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease
AT savastanoluise carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease